Abstract
The aim of the analysis presented in this paper is to study co-infection with hepatitis C virus (HCV) and human immunodeficiency virus (HIV) in injecting drug users (IDUs) using a joint modeling approach that makes use of multivariate statistical methods for current status data. Using marginal models, we estimate association measures between HCV and HIV infections at individual level, i.e., odds ratios and correlation coefficients, and we regress them against some risk factors, e.g., the length of the injecting career, the age at first injection, the ever sharing of syringes, and the frequency of current injecting. In addition, we fit random-effects models that take into account the individual heterogeneity in the acquisition of the infections. For our analysis, we use cross-sectional data from two independent serological surveys, one carried out in Italy (IT) in 2005 on 856 subjects, and the other in three Spanish (ES) cities, between 2001 and 2003, on 589 subjects. We found that the infections are positively associated within individuals, e.g., ORIT=2.56 with 95% confidence interval (CI) (1.43, 6.68) and ORES= 2.42, with 95% CI (1.41, 4.30). We found that the odds ratio and the correlation between HCV and HIV infections increase positively with the length of the injecting career. Moreover, they are found to be significantly positive in case IDUs have never shared syringes or report low injecting frequencies. The variance of the individual random effects is positive, e.g., σb2=0.34 (0.14, 0.62), indicating that there is significant individual heterogeneity in the acquisition of the infections. Our results show that a significant association between HCV and HIV infections within IDUs is related to significant individual heterogeneity in the acquisition of the infections. Indeed, the association between these infections in IDUs who report ever sharing syringes is not significant, which can be explained by a higher homogeneity in their behaviors and, therefore, in their acquisition of the infections.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.